Dawn Parsell Otto, Senior VP, Clinical Development at Tricida, Inc. (TCDA), sold 5,300 shares at $37.11 ($197K) on 2019-10-28, disclosed to the SEC on 2019-10-30.
Open-market sale of $197k TCDA by Senior VP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.11 | 448 | $17K | 8.4% |
| 2 | $37.21 | 3,243 | $121K | 61.1% |
| 3 | $37.22 | 1,162 | $43K | 21.9% |
| 4 | $37.73 | 78 | $3K | 1.5% |
| 5 | $37.78 | 112 | $4K | 2.1% |
| 6 | $37.81 | 257 |
| $10K |
| 4.9% |
| Total | $37.25 avg | 5,300 | $197K | 100% |
| Filing → |
| TCDA | SELL | 2020-04-30 | $172K | — | Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |